Treatment of Behcet’s disease

Journal Title: Chronic Diseases Journal - Year 2013, Vol 1, Issue 1

Abstract

Behcet’s disease is a systemic disease classified among vasculitides. Major manifestations are mucous membrane lesions (oral aphthosis and genital aphthosis), skin manifestations (pseudofolliculitis, erythema nodosum), ocular manifestations (uveitis, retinal vasculitis), joint manifestations, vascular lesions (small to large vessel thrombosis, aneurysm), gastrointestinal manifestations, orchiepididymitis, and some rare manifestations like cardiac, pulmonary, and renal impairment. Diagnosis is mainly clinical. The International Diagnosis Criteria for Behcet’s Disease may be of help. The gold standard of treatment for mucocutaneous lesions is colchicine. In refractory cases, levamisole, thalidomide, and dapsone may be of help. For major organ involvement like the eyes and the brain, immunosuppressive drugs and prednisolone are the gold standard. In refractory cases, biological agents are the last resort. For gastrointestinal manifestations, sulfasalazine and prednisolone are the first-line treatment. For vascular involvement, the first line treatment was anticoagulation, but recently it was shown that immunosuppressive drugs and prednisolone were confirmed to be the best. In all refractory cases and for all different organs, the last resort is biological agents.

Authors and Affiliations

Fereydoun Davatchi, Nasrin Moghimi, Mohammad Mousavi, Alimohammad Fatemi

Keywords

Related Articles

Fahr’s syndrome in a patient with no history of the disease: A case report

Fahr syndrome which presents with various signs and symptoms has a familial predisposition and is characterized by symmetric calcification of basal ganglia. It may present with neuropsychiatric, extrapyramidal, and cereb...

In vivo reprogramming: A new approach for tissue repair in chronic diseases

Medical researchers and biologists have long been fascinated by the possibility of changing the identity of cells, a phenomenon known as cellular plasticity. Now, we know that differentiated cells can be experimentally c...

The role of fatigue and depression in illness perception of patients with multiple sclerosis PDF

BACKGROUND: Fatigue and depression affect the illness perception of patients with multiple sclerosis (MS). The purpose of the present study was to investigate the role of fatigue and depression in illness perception of p...

Investigating the relationship between the level of serum albumin and body mass index, as nutritional indicators, with dialysis adequacy in patients under hemodialysis

BACKGROUND: Patients with end-stage renal disease (ESRD) who undergo hemodialysis have many complications; one of the most important of which is malnutrition, which affects these patients’ quality of life. The aim of thi...

The effects of the health reform plan on the performance indicators of hospitals affiliated with Qazvin University of Medical Sciences, Iran, 2014

BACKGROUND: One of the significant goals of healthcare delivery organizations is to promote people’s health and provide high quality care. In this regard, health reform plan was designed in Iran. Therefore, the present s...

Download PDF file
  • EP ID EP284874
  • DOI -
  • Views 147
  • Downloads 0

How To Cite

Fereydoun Davatchi, Nasrin Moghimi, Mohammad Mousavi, Alimohammad Fatemi (2013). Treatment of Behcet’s disease. Chronic Diseases Journal, 1(1), 42-54. https://europub.co.uk/articles/-A-284874